Antipodes Partners’s TechnipFMC FTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-4,485,245
Closed -$31.4M 35
2020
Q4
$31.4M Sell
4,485,245
-9,169,462
-67% -$53.9M 1.36% 27
2020
Q3
$64.1M Buy
13,654,707
+1,402,011
+11% +$7.88M 2.94% 12
2020
Q2
$62.4M Sell
12,252,696
-100,461
-0.8% -$585K 2.82% 15
2020
Q1
$62M Buy
12,353,157
+5,253,009
+74% +$57.7M 3.24% 17
2019
Q4
$113M Buy
7,100,148
+1,403,285
+25% +$21.8M 5.1% 8
2019
Q3
$102M Buy
5,696,863
+791,719
+16% +$14.8M 4.88% 8
2019
Q2
$94.7M Sell
4,905,144
-756,784
-13% -$13.3M 4.35% 13
2019
Q1
$99.1M Sell
5,661,928
-227,949
-4% -$3.85M 4.9% 9
2018
Q4
$85.8M Buy
5,889,877
+1,315,320
+29% +$24.5M 4.24% 12
2018
Q3
$106M Buy
4,574,557
+416,671
+10% +$9.45M 4.94% 11
2018
Q2
$98.2M Sell
4,157,886
-1,746,635
-30% -$41.6M 4.67% 9
2018
Q1
$129M Buy
5,904,521
+1,466,312
+33% +$34M 5.8% 8
2017
Q4
$103M Buy
4,438,209
+1,742,396
+65% +$36.1M 6.05% 6
2017
Q3
$55.9M Buy
+2,695,813
New +$54.1M 4.11% 12

Other funds holding FTI

Antipodes Partners's FTI Position: Q1 2021 in Review

Antipodes Partners sold out of TechnipFMC (FTI) in Q1 2021, closing a stake of 4,485,245 shares — an estimated $31.4M sold.

Antipodes Partners first reported a position in FTI in Q3 2017 and held it in 14 quarters. The position peaked at $129M in Q1 2018. 266 funds tracked by Wall St. Rank hold FTI as of Q1 2021.

  • Antipodes Partners reported no remaining TechnipFMC position as of Q1 2021 after selling out during the quarter.
  • Antipodes Partners sold 4,485,245 TechnipFMC shares in Q1 2021, an estimated $31.4M.
  • Antipodes Partners first reported a position in TechnipFMC in Q3 2017 and held it in 14 quarters.
  • Antipodes Partners's TechnipFMC position peaked at $129M in Q1 2018.
  • 266 funds tracked by Wall St. Rank held TechnipFMC as of Q1 2021.

Based on Antipodes Partners's 13F filing for Q1 2021, filed 13 May 2021.